In one paragraphArticle in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Martina RuecaLaboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0001-5162-046X Sara LeoneClinical Epidemiology and Biostatistics Unit, Department of Epidemiology, Preclinical Research and Advanced Diagnostic, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0009-0006-3723-0127 Maria Beatrice ValliLaboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0001-5022-5388 Gabriella De CarliRegional Service for Surveillance and Control of Infectious Diseases (SERESMI), National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0002-3972-8301 Gaetano MaffongelliClinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0001-7784-2511 Eleonora LalleLaboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.
Federica ForbiciLaboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0002-3954-5679 Maria Concetta FuscoRegional Service for Surveillance and Control of Infectious Diseases (SERESMI), National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.
Alessandra AmendolaLaboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0002-7063-0222 Lavinia FabeniLaboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0002-2975-8611 Maria Letizia GiancolaClinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.
Alessandro AgrestaRegional Service for Surveillance and Control of Infectious Diseases (SERESMI), National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0001-8890-0342 Tommaso Ascoli BartoliClinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.
Emanuele NicastriClinical Department, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0002-5606-8712 Fabrizio MaggiLaboratory of Virology and Laboratories of Biosecurity, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.ORCID 0000-0001-7489-5271 Francesco VairoRegional Service for Surveillance and Control of Infectious Diseases (SERESMI), National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The mitigation measures adopted to reduce the spread of COVID-19 have not only impacted the transmission of respiratory infections but also other infectious diseases. In this study, we explored the effect of the pandemic on the epidemiology of Central Nervous System (CNS) infections by conducting a retrospective analysis of diagnostic data obtained from cerebrospinal fluids (CSFs) collected before, during, and after the pandemic from patients with acute-suspected neuro-infectious syndrome. The samples were analyzed using a meningitis/encephalitis molecular syndromic panel. A total of 4203 CSFs were split into three groups: pre-pandemic (August 2018-February 2020), pandemic (March 2020-March 2022) and post-pandemic (April 2022-March 2024). Each pathogen was statistically assessed individually, comparing one group vs. another. Results showed that viral pathogens were the most frequently detected across all groups; however,
Indexed as
Central Nervous System InfectionsCOVID-19HumansItalyPandemicsRetrospective StudiesSARS-CoV-2enterovirusmeningo-encephalitismolecular diagnosticsSARS-CoV-2
Identifiers
PMID42655704
PMCPMC13517623
What OpenQuestion holds
Textmetadata
Read underepoch 390